Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: SnowShredder who wrote (4567)	4/6/1998 11:16:00 PM
From: Russian Bear	Respond to of 9719

Thanks, WHG?. I saw that news release, but it has not helped to give me an insight into what is really happening. I cannot believe that the FDA really needs more time to make a determination. Not after all the time that has already elapsed. So, why not simply recommend denial of the myotrophin NDA, if that is what they are going to do? Conversely, why not recommend approval, if that is their intention? There appears to be another piece of information that is missing. Could it be political? I couldn't decide whether it was appropriate to take a long or a short position, and buying the straddle was too dear, so I ended up doing nothing. Maybe, that is just as well. Regards, RB